Raporty Spółek ESPI/EBI

Publishing of Annual individual audited financial statement for 2025 SOPHARMA AD (BG11SOSOBT18)

30-03-2026 10:08:08 | ESPI | 114/2026
oUNI-EN: Publishing of Annual individual audited financial statement for 2025

 PAP
Data: 2026-03-30
Firma: SOPHARMA AD
oSpis tresci:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

oSpis zalacznikow:
Znaleziono 1 załącznik
  • 097900BGGW0000048796-20251231-EN-SEP.rar
    		•  Arkusz: REPORT

    Nazwa arkusza: REPORT


    POLISH FINANCIAL SUPERVISION AUTHORITY
    UNI - EN REPORT No 114 / 2026
    Date of issue: 2026-03-30
    Short name of the issuer
    SOPHARMA AD
    Subject
    Publishing of Annual individual audited financial statement for 2025
    Official market - legal basis
    Art. 56. 1. 2 of Act on Public Offering
    Unofficial market - legal basis
    Contents of the report:

    Sofia, Bulgaria, 30 March 2026 - According to the requirements of art. 100n of LPOS, "Sopharma" AD _SFA: "BSE-Sofia" AD, SPH: Warsaw Stock Exchange_ presents the Annual Audited Individual Financial Statements, which contains:

    - XHTML format of the report in accordance with the requirements of Commission Delegated Regulation _EU_ 2018/815 of 17 December 2018 supplementing Directive 2004/109/EC of the European Parliament and of the Council with regulatory technical standards on the definition of a common electronic format for reports. It contains:
    - Annual financial statements according to IFRS;
    - Notes to the annual financial statements;
    - Annual management report and non-financial declaration;
    - Corporate governance Declaration;
    - Report on the implementation of the remuneration policy;
    - Declaration by the responsible persons;
    - Audit report; and
    - Audit declaration.
    - Annual reports according to a template determined by the Deputy Chairman of the Financial Supervision Commision;
    - Corporate Governance Scorecard;
    - Electronic reference to the published inside information under Article 7 of Regulation _EU_ ą596 / 2014 of the European Parliament and of the Council of 16 April 2014 on market abuse _Market Abuse Regulation_ and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC _OJ L 173/1 of 12 June 2014_ _Regulation _EU_ ą 596/2014_ on the circumstances during the past year:
    http://www.x3news.com/?page=News_uniqid=6242d3eba9dc7
    https://www.sopharmagroup.com/en/home/investors/investor-news/public-disclosure-of-inside-information-in-compliance-with-article-17-of-regulation-eu-no-596-2014-on-market-abuse
    Annexes
    File Description
    097900BGGW0000048796-20251231-EN-SEP.rar Publishing of Annual individual audited financial statement for 2025

    Nazwa arkusza: INFORMATION ABOUT THE ENTITY


    SOPHARMA AD
    _fullname of the issuer_
    SOPHARMA AD Farmaceutyczny _far_
    _short name of the issuer_ _sector according to clasification
    of the WSE in Warsow_
    1220 Sofia
    _post code_ _city_
    IlienskoShosse 16
    _street_ _number_
    +359 2 813 42 00 +359 2 936 02 86
    _phone number_ _fax_
    _e-mail_ _web site_
    nd
    _NIP_ _REGON_

    Nazwa arkusza: SIGNATURE OF PERSONS REPRESENTING THE COMPANY


    SIGNATURE OF PERSONS REPRESENTING THE COMPANY
    Date Name Position / Function Signature
    2026-03-30 Ognian Ivanov Donev Executive Director


    Identyfikator raportu jjvuszwyf1
    Nazwa raportu UNI-EN
    Symbol raportu UNI-EN
    Nazwa emitenta SOPHARMA AD
    Symbol Emitenta SOPHARMA AD
    Tytul Publishing of Annual individual audited financial statement for 2025
    Sektor Farmaceutyczny (far)
    Kod 1220
    Miasto Sofia
    Ulica IlienskoShosse
    Nr 16
    Tel. +359 2 813 42 00
    Fax +359 2 936 02 86
    e-mail
    NIP nd
    REGON
    Data sporzadzenia
    Rok biezacy 2026
    Numer 114
    adres www
    Serwis Ekonomiczny Polskiej Agencji Prasowej SA 2026 Copyright PAP SA - Wszelkie prawa zastrzezone.